Revenue Breakdown
Composition ()
No data
Revenue Streams
Bio-Techne Corp (TECH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 80.8% of total sales, equivalent to $231.60M. Other significant revenue streams include Service and Instruments. Understanding this composition is critical for investors evaluating how TECH navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, Bio-Techne Corp maintains a gross margin of 65.29%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 21.10%, while the net margin is 12.85%. These profitability ratios, combined with a Return on Equity (ROE) of 3.96%, provide a clear picture of how effectively TECH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TECH competes directly with industry leaders such as PCVX and ARWR. With a market capitalization of $9.05B, it holds a leading position in the sector. When comparing efficiency, TECH's gross margin of 65.29% stands against PCVX's N/A and ARWR's 100.00%. Such benchmarking helps identify whether Bio-Techne Corp is trading at a premium or discount relative to its financial performance.
